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This study reviews the FMDV receptor-binding domain, integrin receptors, and heparan sulfate receptors to provide
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Foot-and-mouth disease (FMD) is a highly contagious and
fulminating infectious disease in mammals. Although its
mortality in adult animals is not high, its mortality in
young animals is relatively high. After infection, the mor-
bidity in animals reaches almost 100%. FMD is listed as
the number one infectious disease by the Office Inter-
national des Epizooties (OIE) in France [1]. Foot-and-
mouth disease virus (FMDV) belongs to the family Picor-
naviridae, which has 7 serotypes (O, A, C, SAT1, SAT2,
SAT3, and Asia I) and many subtypes [2]. FMDV infects
many cloven-hoofed animals and causes serious eco-
nomic, political, and social problems [3]. Currently, no
effective drug for treating FMD; thus, its danger is obvi-
ous [4,5].
Host cell adsorption is a prerequisite for FMDV to
infect cells. This adsorption process depends on host cell
receptors. Viruses initiate the infection process through
binding to specific receptors on the cell surface of sus-
ceptible host cells. Host tissues and specific cell surface
receptors determine the invasion routes and dissemi-
nation methods of viruses as well as the pathogenic
features of hosts [6]. Studies regarding the FMDV ligand
and cell receptors help to not only understand FMDV
cell receptors but also to elucidate the infection routes,
replication process, pathogenesis, and host tropism of
FMDV, providing scientific bases for the prevention,* Correspondence: zhangzhidong@caas.cn; hnxiangtao@163.com
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unless otherwise stated.control, and treatment of FMD. This article reviews
the progress of studies regarding the FMDV receptor-
binding domain (ligand) and its receptors to provide
references for studying mechanisms underlying FMDV
infection and for the prevention and treatment of this
disease.Review
FMDV receptor-binding domain (ligand) and FMDV infection
The genome of FMDV is a single-stranded, positive-sense
RNA, which serves as both mRNA and the template for
negative-stranded RNA. The genome of FMDV is com-
posed of approximately 8,500 nucleotides (nt) and has the
following 3 components: a 5′-untranslated region (5′-
UTR), an open reading fragment (ORF), and a 3′-UTR.
The ORF encodes a polyprotein that forms the following 4
fragments after the primary cleavage: the L fragment, the
P1/2A fragment, the P2BC fragment, and the P3 fragment.
After the secondary cleavage and the maturation cleavage,
4 structural proteins (VP4, VP2, VP3, and VP1) and 8–9
non-structural proteins (Lab/Lb, 2A, 2B, 2C, 3A, 3B1,
3B2, 3B3, 3C, and 3D) are formed [2].
The capsid proteins of FMDV are composed of 60
copies of the 4 structural proteins VP1, VP2, VP3, and
VP4 (also known as 1D, 1B, 1C, and 1A) of FMDV and
display an icosahedral structure [7]. One copy of VP1,
VP2, VP3, and VP4 proteins forms a protomer; 5 proto-
mers assemble into a pentamer; and 12 pentamers form
a complete viral capsid [8,9]. The capsids of FMDV par-
ticles have many small holes that are surrounded by 5
identical protomers composed of VP1, VP2, VP3, and
VP4. VP1 is close to the small hole, VP2 and VP4 are at
the distal end, and VP4 is completely inside of theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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particles is a surface-protruding G-H loop formed by the
βG and βH chains of residues 140–160 of VP1. The G-H
loop contains a highly conserved arginine-glycine-aspartate
(Arg-Gly-Asp, RGD) sequence. This sequence is an impor-
tant neutralizing site of FMDV [10]; this sequence is also
the primary component of the cell adsorption site and can
interact with integrin receptors on the cell membrane to
mediate the initiation of virus infection [7,11]. Except
for VP4, the capsid proteins VP1, VP2, and VP3 are all
associated with antigenicity and can interact with the
RGD-directed integrin protein subunits and with hepa-
ran sulfate proteoglycans (HSPGs) on the cell surface.
The variations of the amino acid residues in FMDV cap-
sid proteins that form viral particles not only can affect
the adsorption ability between viruses and cell receptors
but also may affect the biological characteristics of
viruses [10,12,13].
The RGD sequence of the G-H loop in the VP1 capsid
protein of FMDV has been shown to form an extremely
stable complex with cellular integrin proteins, and this
complex is resistant to EDTA. The replacement of spe-
cific amino acids demonstrated that the stability of bind-
ing to αvβ6 depends on a helical structure close to the
RGD sequence. The leucine residues at RGD + 1 and
RGD + 4 sites are the key positions for this stable inter-
action. The stability of this complex helps to increase
the possibility of virus adsorption and internalization,
thus increasing FMDV infectivity [14]. The study by
Escarmis et al. [15] regarding the crystallographic struc-
ture of viral particles using X-ray scattering demon-
strated that the G-H loop of VP1 was highly disordered.
When the viral capsid interacted with the antigen-
binding fragment (Fab), this loop protruded from the
viral capsid. Then, the RGD sequence in the G-H loop
interacted with the cellular integrin receptors, and the
virus infected cells through internalization.
In addition to the RGD sequence, FMDV can also
utilize other tripeptide sequences similar to the RGD
sequence to interact with receptors. Martinez et al. [16]
demonstrated that when the RGD sequences were chan-
ged to REG sequences, FMDV could still replicate nor-
mally in its susceptible cells. Therefore, these authors
speculated that FMDV might use other unknown mech-
anisms to recognize cells. In addition, FMDV is an RNA
virus, which has the characteristics of quasispecies in
nature. After being passaged for several generations in
chicken embryos or cells or under external conditions,
such as vaccine pressure, FMDV can produce many
different antigenic variants. These variant strains can
cause infection independent of the RGD sequence.
For example, when the FMDV strain C-S8c1 was passaged
in cells for 100 generations, a mutant strain containing the
Arg-Gly-Gly (RGG) receptor-binding sequence appeared.When this RGG containing mutant strain was passaged
for 50 generations in cells, a mutant strain containing the
Gly-Gly-Gly (GGG) receptor-binding sequence appeared.
These results indicated that FMDV could produce viable
and infectious virions that did not depend on the RGD
sequence in addition to primarily depending on the
RGD sequence during the process of evolution. Further-
more, these viral variants could use a currently unknown
method to interact with cells, causing adsorption and
infection [17-19]. However, studies regarding the function
of these mutated receptor binding sites and cell entry,
followed by the recognition of cellular protein mole-
cules, remain lacking; therefore, whether variations in
these receptor-binding sites cause changes in host tropism
remains unclear [20].
Integrin-mediated FMDV infection
The mechanism underlying integrin-mediated FMDV infection
and integrin proteins that mediate FMBV infection
Integrins are a family of extensively distributed cell sur-
face receptors. Members of this family are all heterodi-
meric transmembrane glycoproteins containing α and β
subunits formed by non-covalent interactions. The sub-
units of integrins belong to the type I transmembrane
proteins, which include a large extracellular domain, a
small transmembrane domain, and a cytoplasmic domain.
Each chain consists of an extracellular region, a trans-
membrane region, and a cytoplasmic region. The spherical
region formed by the N-terminal α and β chains is the
extracellular ligand-binding domain. Integrins primarily
mediate cell adhesion and signal transduction and partici-
pate in many physiological functions, such as cell growth,
development, differentiation, and apoptosis [21]. Some
studies have demonstrated that integrin-mediated FMDV
infection occurs through clathrin-dependent endocytosis;
acidified endocytic vesicles cause rapid cleavage of the
viral capsid protein structure, thus causing RNA release
through a currently unknown mechanism [22]. At least 18
known different α and β subunits that form 24 different
αβ heterodimers have been identified [23]. Only 8 integ-
rins (αvβ1, α5β1, αvβ3, αvβ8, αvβ5, αvβ6, α8β1, and αII
bβ3) can interact with the RGD sequence in the G-H loop
of FMDV VP1 [24]. At least 4 integrins (αvβ1, αvβ3, αvβ6,
and αvβ8) can be used as FMDV receptors to mediate
FMDV infection [25-28].
αvβ3 integrin-mediated FMDV infection
αvβ3 is the first discovered FMDV receptor [25]. In 1995,
Berinstein et al. [25] found that the anti-serum against
αvβ3 of the human vitronectin receptor and a monoclonal
antibody against αvβ3 could both block FMDV infection
in susceptible cells; therefore, αvβ3 was confirmed to be a
cellular receptor for this virus. X-ray scattering studies
have demonstrated that the extracellular portion of αvβ3
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are in the α subunit and 8 of which are in the β subunit.
These domains form a functional molecule with an oval
head and two tails [29] (Figure 1). The tails are the active
sites and are associated with the cellular regulatory mech-
anism. The BA domain contains a metal ion-dependent
adhesion site close to a calcium-binding site, which has
regulatory functions [30]. In 2001, Neff et al. [31] demon-
strated that the truncation or extension of the cytoplasmic
region of αv and β3 subunits, including the deletion of
the entire cytoplasmic region, had no or minor effects
on αvβ3 as a receptor for FMDV. In addition, FMDV
replication was inhibited by an αvβ3 antibody but not
by antibodies of other RGD-directed integrins including
αvβ5, αvβ1, and αvβ6. αvβ6 antibodies inhibit in one
case [27] but not the other. In 2005, Monaghan et al.
[32] monitored αvβ3 and αvβ6 expression in bovine
epithelial cells of FMDV target tissues using immuno-
fluorescence confocal microscopy and real-time RT-
PCR. The results indicated that the surface of epithe-
lial cells with a high FMDV replication level during
natural infection expressed αvβ6 but not αvβ3 and
that FMDV infected cells in interdigital skin also
expressed αvβ6. These data indicated that αvβ3 was
not a major receptor of tissue tropism for FMDV to
infect target epithelial cells. The αvβ3 integrin protein
might be an adsorption receptor for viruses because
the deletion of the cytoplasmic domain of the αv or
β3 subunit did not affect the efficiency of viral infec-
tion; thus, other cell surface molecules might serve as
co-receptors and play a role in the internalization
process of viruses [31].
αvβ6 integrin-mediated FMDV infection
In 2000, Jackson et al. [26] demonstrated that human
colon carcinoma SW480 cells nonpermissive for FMDVFigure 1 Integrin binding domain with the G-H loop and RGD sequen
the FMDV VP1 GH loop (as in panel A) in the context of αvβ3. The loop is
(yellow/green ribbon) and the ligand-binding domain of β3 (purple/pink ri
Leu (RGD + 1 and RGD + 4) shown as orange sticks projecting from the samunder normal conditions became susceptible to FMDV
after transfection with human β6 integrin cDNA. This
infection could be suppressed by an anti-αvβ6 monoclo-
nal antibody, and this interaction was dependent on the
RGD sequence. Therefore, αvβ6 was identified as an-
other functional receptor for FMDV. The β6 subunit can
only form a heterodimer, αvβ6; αvβ6 belongs to a sub-
group of the integrin family. This subgroup can use a
common RGD sequence [32]. αvβ6 is only expressed in
epithelial cells; however, its expression levels in different
epithelial cells vary. αvβ6 has high expression levels in
the epithelial cells of the macula densa and endometria
as well as in tongue epithelial cells and salivary glands;
however, αvβ6 has low expression levels in skin and lung
epithelial cells [33,34]. Brown et al. [35] cloned the sheep
β6 subunit and confirmed that αvβ6 expression was low
in sheep epithelial cells using RT-PCR and immunohis-
tochemistry. αvβ6 could be detected in the epithelial
cells of the airways, oral cavity, gastrointestinal tract,
kidney, sweat glands, and hair follicular sheath and in
the epidermis of the pedal coronary band but not of
normal skin. In addition, αvβ6 was highly expressed in
ovine tonsillar crypt epithelial cells and in bovine and
ovine tracheal epithelial cells, indicating that tracheal
epithelial cells might be the portal of entry in ruminants
at the early stage of FMDV infection. The results of
Du et al. [36] were similar to those results of Monaghan
et al. [37] demonstrating that αvβ6 is primarily dis-
tributed in the spinous layer of epithelial cells and
that αvβ3 is only expressed at low levels in the vascular
system. These results suggested that αvβ6 might be the
major functional receptor determining FMDV tissue
tropism. The tissue distribution of αvβ3 seemed to be
unrelated to the tissue tropism of viruses; however, its
function at the late stage of viral infection could not be
excluded.ce of VP1 [29]. Panel A shows the FMDV VP1 GH loop. Panel B shows
predicted to bind in the crevice between the αv β-propeller domain
bbon). Panel C shows a close up of panel B with the side chains of
e face of the 310 helix.
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the process of its involvement in the infection of cells by
viruses remains unclear. In 2001, Miller et al. [38] par-
tially or completely deleted the cytoplasmic domain of
β6 and found that its binding to viruses was not affected
but that viral infection was affected, indicating that this
region plays an important role after virus interaction. In
2005, Berryman et al. [39] and O′Donnell [22] both
simultaneously reported that FMDV infection of αvβ6-
expressing cells was associated with the endocytosis
function of integrins in the porous structure and that
this endocytosis function was mediated by clathrin.
Together with the acidification of endosomes, this endo-
cytosis function induced the degradation of the viral
capsid structure to release genomes. This mechanism
remains unclear, and no lipid raft-dependent caveolin
or other endocytosis pathway appeared to be involved.
Some studies have demonstrated that αvβ6 integrin
not only functions in the cell adsorption process of
FMDV but also plays important roles in the process
of virus uncoating and replication [39]. Neff et al. [31]
deleted most amino acid residues in the C-terminus of the
cytoplasmic domain of human β6 or in the core region
containing the “NPLY” sequence and demonstrated that
the mutant β6 could not normally mediate FMDV infec-
tion. These results confirmed the important role of the
conserved “NPLY” sequence of the integrin cytoplasmic
domain in cell signal transduction. In addition, Miller
et al. [38] demonstrated that the β6 subunit could facili-
tate cell growth because of the C-terminal 11 amino acids.
In comparison, soluble αvβ3 could not bind to particular
type A or type O viruses; however, these two types of
viruses could bind to particular integrins, indicating that
the binding between FMDV and αvβ3 was a low affinity
interaction. In addition, soluble αvβ3 could not inhibit
virus infection. Incubation with soluble αvβ6 could signifi-
cantly inhibit the interaction between the A12 or O1 type
FMDV and BHK cells, whereas incubation with soluble
αvβ3 only had low levels of inhibition. These results indi-
cated that at least in vitro soluble receptors could interfere
with FMDV infection of cells, establishing foundations for
the utilization of soluble receptors and for the deve-
lopment of anti-integrin protein drugs for the control
of FMD [40].
αvβ1 integrin-mediated FMDV infection
In 2002, Jackson et al. [27] discovered that FMDV could
not infect CHOB2 cells with αv subunit expression defi-
ciency under normal conditions. After transfecting human
αv cDNA into CHOB2 cells, these cells began to express
heterologous αvβ1 integrin (human αv/hamster β1) and
became susceptible to FMDV. These results confirmed
that αvβ1 can serve as a functional receptor for FMDV.
αvβ1-mediated virus adsorption could be blocked bymonoclonal antibodies against αv or an RGD sequence
containing a short peptide, which confirmed that the αv
subunit contained the major virus-binding domain [27].
The expression of αvβ1 integrin is restricted in some spe-
cific cells; for example, malignant tumor cells, smooth
muscles, and the central nervous system express αvβ1
[41]. Some cells express many αv and β1 subunits but do
not express αvβ1 heterodimers, causing some difficulties
in αvβ1 research.
αvβ1 integrin is ineffective under physiological con-
centrations of calcium and magnesium ions. However,
treating cells with manganese ions or with an anti-β1
antibody with an activation function significantly in-
creased the infectivity of FMDV in cells. Therefore, the
ability of FMDV to utilize αvβ1 as a virus receptor might
depend on a cellular regulatory mechanism underlying
the interaction between integrin protein molecules and
ligands [27,39].
αvβ8 integrin-mediated FMDV infection
In 2004, Jackson et al. [28] transfected human β8 cDNA
into SW480 cells nonpermissive for FMDV infection.
This cell line expressed αvβ8 on the cell surface and
became susceptible for FMDV. Treating these cells with
specific monoclonal antibodies against αvβ8 hetero-
dimers or αv subunits could block FMDV infection.
Therefore, αvβ8 was confirmed as the fourth discovered
functional integrin receptor for FMDV, after αvβ3, αvβ6,
and αvβ1. In addition, Cambier et al. [42] in 2000 and
Fjellbirkeland et al. [43] in 2003 both identified αvβ8
expression in airway epithelial basal cells in mammals,
which is the primary proliferation site of FMDV. These
results indicated that αvβ8 might function at the early
stage of FMDV infection and might affect the tropism
and pathogenesis of viruses.
To study the roles of different integrins in the viral in-
fection process, Duque and Baxt [44] cloned bovine αv,
β1, β3, β5, and β6 integrin subunits and transiently
transfected these subunits into cells to compare the
utilization rates of αvβ1, αvβ3, αvβ5, and αvβ6 by three
strains of serotype A and by two strains of serotype O
FMDV. The results demonstrated that the three strains
of type A viruses could utilize αvβ3 and αvβ6 with rela-
tively high efficiency and could utilize αvβ1 with moder-
ate efficiency, whereas the two strains of type O viruses
utilized αvβ6 and αvβ1 with higher efficiency than αvβ3.
All viruses could only replicate at low levels in cells ex-
pressing αvβ5. Experiments in which the ligand-binding
domains among the β subunits were exchanged indicated
that this ligand-binding region was helpful for elucidating
the differences in integrin utilization by different strains of
viruses. Infection with different strains of viruses might
result in different severities of diseases; however, in most
cases, the clinical symptoms of the same species did not
Wang et al. Virology Journal  (2015) 12:9 Page 5 of 7have significant difference. This observation might be as-
sociated with the expression patterns and expression levels
of FMDV integrin receptors among different species.
Heparan sulfate-mediated FMDV infection
Heparan sulfate (HS) is a highly sulfated glycosaminogly-
can (GAG). GAGs, which are long unbranched polysac-
charides consisting of a repeating disaccharide unit
(hexosamine, hexuronic acid, or galactose), extensively
exist in the cell membrane and in the extracellular
matrix. Under physiological conditions, the N-sulfate
group or the O-sulfate group in the HS carbon chain
provides many negative charges to the sugar chain. This
sulfated polysaccharide sequence structure provides
HSPGs with not only their anionic feature and high
density negative charges but also the ability to interact
with other extracellular substances, including viruses
[45]. In 1996, Jackson et al. [46] demonstrated that hep-
arin could specifically block FMDV infection in cultured
cells and that heparin-treated cells had significantly re-
duced plaque formation after FMDV infection. In addition,
FMDV could not infect HS-deficient cells. These results
confirmed that HS on the cell membrane is a receptor
for FMDV.
HS was originally considered a co-receptor for the O
type FMDV strain to enter cells [46]. Subsequent studies
have demonstrated that other serotypes (such as A, C,
Asia1, and SAT1) of FMDV could also bind to HS [47].
Baxt [48] found that the A type FMDV could not bind
to CHO cells only expressing the HS receptor, whereas
the O type FMDV VP3 (Arg56) mutant strain could
replicate in CHO cells. In contrast, the VP3 (His56) mu-
tant strain could not replicate. These results indicatedFigure 2 Model of the interaction of FMDV with heparan sulfate rece
The RGD integrin-binding motif is shown in a magenta surface representatthat HS could have a direct electrostatic adsorption
function with the positively charged arginine residue at
position 56 in the VP3 protein. Other studies have dem-
onstrated that the C-terminal amino acids at positions
201–211 of VP1 might participate in the adsorption
process between viruses and cells. The sequences of the
C-terminal 201–211 region of VP1 are similar to the
heparin-binding site of vitronectin, suggesting that this
region might interact with HS. However, the crystal
structure of the FMDV and HS complex did not display
the same result. The histidine at position 195 and the
lysine at position 193 of VP1 in the O1BFS and A10
strains were both linked with HS, suggesting that the C-
terminus of VP1 might facilitate the interaction between
these residues and HS. The analysis of the crystal struc-
ture indicated that the HS-binding site of FMDV was
approximately 15 Å from the RGD sequence; the spatial
locations of these two were extremely close [7,49,50]
(Figure 2), suggesting that integrin and HS receptors
might simultaneously interact with FMDV to mediate
FMDV infection [51]. Whether this situation can be ap-
plied for all FMDV still awaits further validation. Jack-
son et al. [46] once considered that HS was the first step
for virus-cell interaction, followed by virus-integrin
interaction. Some scholars have demonstrated that the
HS receptor mediated FMDV infection through Caveola-
dependent endocytosis pathway [52,53]. However, because
different strains of FMDV can use different types of re-
ceptors, evidence demonstrating the functional relation
between HS and integrin remains lacking. Many studies
have indicated that HS might be a replacement receptor
for FMDV or an alternative pathway for entry into cells
after virus infection [54].ptor [7,49,50]. The small orange oval indicates the HS-binding site.
ion [50].
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In addition to utilizing integrins and HS for FMDV recep-
tors, a hypothesis regarding a third group of receptors
for FMDV was proposed. For example, Baxt et al. [55]
found that FMDV could infect macrophages through Fc
receptor-mediated adsorption. Rieder et al. [56] utilized
genetic engineering to fuse a single-chain antibody (scab)
that could interact with viruses to intercellular adhesion
molecule 1 (ICAM 1) to produce a new FMDV receptor
(scAb/ICAM 1). FMDV A12 could infect CHO cells ex-
pressing this replacement receptor but not normal CHO
cells. After the RGD sequence in the FMDV C-S8c1 strain
was mutated into RGG, this strain could obtain viability in
K653 cells that did not express αvβ3. Zhao et al. [57] con-
structed a chimeric virus using cDNA from the FMDV
A12 infectious clone O/CHA/90 and its cell-adapted
strain vac-O/CHA/90. When the RGD sequence was
artificially mutated into KGE, the chimeric virus could still
grow in cultured cells after HS utilization was excluded.
Other discovered natural mutations in the cell adsorption
site of FMDV included GGD, TGD, RDD, PGD, KGN,
RSG, KGD, and IGD [20,47,54]. These experimental re-
sults indicated that a third group of FMDV receptors
might mediate FMDV infection.
Conclusions
Receptors are the major determinant factors for the
tropism and pathogenesis of viruses. Viruses may utilize
different receptors at the different stage of viral patho-
genesis. FMDV is the only virus in the Picornaviridae
family that can utilize 4 different integrin proteins, αvβ1,
αvβ3, αvβ6, and αvβ8, to mediate infection. However,
the function of each receptor in the process of host
cell infection by FMDV remains unknown. In addition,
under the conditions of adapted cell culture, FMDV ob-
tains the ability to utilize HS as its receptor. Although this
feature is associated with reduced virulence, yet unidenti-
fied receptor may be associated with the infection of cells
by FMDV. In addition, different serotypes of FMDV
strains have different efficiencies for receptors during the
process of infecting cells. Therefore, investigating FMDV
receptors provides experimental data for understanding
the mechanism underlying the infection of cells by dif-
ferent serotypes of FMDV, the influencing factors (in-
cluding the expression profiles of host cell receptors
and virulence-related genes, the structural changes of
the receptor-recognition regions, and the viral load),
and the evaluation of the virulence of FMDV epidemic
strains and their host ranges. These investigations also
establish a theoretical foundation for elucidating the
molecular mechanisms underlying host tropism and
cross-species FMDV infection. Investigating the mech-
anism underlying the utilization of receptors to mediate
cell infection by FMDV can theoretically unravel thestructure of FMDV receptors and their roles in the
process of FMDV infection of host cells, thus facilitating
the design of corresponding chemical drugs to block the
interaction between FMDV and host cells and providing
new insights and methods for the prevention and control
of FMD.
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